ProPharma is committed to ensuring clients achieve optimal results. As your Benchling partner, our team of R&D Technology experts will ensure you obtain the most value from your Benchling software investment.

A global team of trusted experts for multi-phase clinical development.

Today’s clinical researchers need precise, timely, and reliable solutions for managing huge amounts of diverse data. TrialKit AI is here to meet this demand.

Identify & engage healthcare professionals (HCP) treating eligible patients—in near real-time

Timely physician engagement is critical to therapy adoption. Quest Diagnostics combines near real-time lab data with other data sources including EHR, claims and prescription data to help pharmaceutical teams identify and connect with physicians managing eligible patients at key decision time point in the patient journey.

In today’s competitive pharmaceutical landscape, ensuring that physicians receive timely, relevant information about new therapies is essential. Quest’s unique combination of industry-leading deidentified lab data, enhanced with claims, prescription (Rx), and EHR insights, allows pharma teams to refine targeting, optimize engagement, and drive better patient outcomes.

The Revvity Signals Software Risk-Based Monitoring Solution is the most effective way to leverage data-driven insights to optimize site performance while improving patient safety.

Streamline real-time data access and analysis with iMedNet's Report Manager.

A centralized command center for patient randomization and drug supply management—built for today’s complex clinical trials.

Navigating drug safety in the era of innovation-driven medicine

The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.